{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:22:30Z","timestamp":1790205750924,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.pupt.2018.06.004","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T10:48:10Z","timestamp":1531133290000},"page":"48-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["The pharmacological treatment of chronic comorbidities in COPD: mind the gap!"],"prefix":"10.1016","volume":"51","author":[{"given":"Umberto","family":"Vespasiani-Gentilucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1847-9032","authenticated-orcid":false,"given":"Claudio","family":"Pedone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Muley-Vilamu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Antonelli-Incalzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2018.06.004_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1164\/ajrccm\/148.2.418","article-title":"Chronic obstructive pulmonary disease. An original model of cognitive decline","volume":"148","author":"Incalzi","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib3","doi-asserted-by":"crossref","first-page":"43S","DOI":"10.1378\/chest.08-0342","article-title":"Anxiety and depression in COPD: current understanding, unanswered questions, and research needs","volume":"134","author":"Maurer","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/COPD.S63485","article-title":"Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values","volume":"9","author":"Dal Negro","year":"2014","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2147\/NDT.S79354","article-title":"Strategies to improve anxiety and depression in patients with COPD: a mental health perspective","volume":"12","author":"Tselebis","year":"2016","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.pupt.2018.06.004_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","article-title":"Drug effects on salivary glands: dry mouth","volume":"9","author":"Scully","year":"2003","journal-title":"Oral Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1378\/chest.12-1911","article-title":"Bidirectional associations between clinically relevant depression or anxiety and COPD: a systematic review and meta-analysis","volume":"144","author":"Atlantis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib8","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2147\/COPD.S49622","article-title":"Self-management in patients with COPD:theoretical context, content, outcomes, and integration into clinical care","volume":"9","author":"Kaptein","year":"2014","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"European working Group on sarcopenia in older people. Sarcopenia: European consensus on definition and diagnosis: report of the European working Group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.pupt.2018.06.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2017.11.006","article-title":"Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables","volume":"134","author":"de Blasio","year":"2018","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1183\/09059180.00008612","article-title":"Comorbidities of COPD","volume":"22","author":"Cavaill\u00e8s","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.pupt.2018.06.004_bib12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.pupt.2018.06.004_bib13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/jbmr.061202","article-title":"Osteoporosis-related kyphosis and impairments in pulmonary function: a systematic review","volume":"22","author":"Harrison","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.pupt.2018.06.004_bib14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jocd.2009.05.003","article-title":"Osteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO study","volume":"12","author":"Maggi","year":"2009","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.pupt.2018.06.004_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-015-0192-8","article-title":"Fracture prevention in COPD patients; a clinical 5-step approach","volume":"16","author":"Romme","year":"2015","journal-title":"Respir. Res."},{"key":"10.1016\/j.pupt.2018.06.004_bib16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/thx.2009.120659","article-title":"Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene","volume":"65","author":"Janssens","year":"2010","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2018.06.004_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/thx.2011.160028","article-title":"Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"66","author":"Loke","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.pupt.2018.06.004_bib18","series-title":"Molecular Basis of Nutrition and Aging","first-page":"411","article-title":"Nutritional status in aging and lung disease","author":"Antonelli Incalzi","year":"2016"},{"key":"10.1016\/j.pupt.2018.06.004_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1164\/rccm.200811-1691OC","article-title":"Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension","volume":"179","author":"Fisher","year":"2009","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib20","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1164\/rccm.200210-1130OC","article-title":"Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease","volume":"167","author":"Arcasoy","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.thromres.2003.12.003","article-title":"Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD","volume":"112","author":"Ambrosetti","year":"2003","journal-title":"Thromb. Res."},{"key":"10.1016\/j.pupt.2018.06.004_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1378\/chest.102.1.17","article-title":"The diagnosis of acute pulmonary embolism in patients with chronic obstructive pulmonary disease","volume":"102","author":"Lesser","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.chest.2016.07.034","article-title":"Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and meta-analysis","volume":"151","author":"Aleva","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.pupt.2018.06.004_bib25","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1056\/NEJM198106253042606","article-title":"Inhibition of hypoxic pulmonary vasoconstriction by nifedipine","volume":"304","author":"Simonneau","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1378\/chest.121.2.361","article-title":"Oropharyngeal deglutition in stable COPD","volume":"121","author":"Mokhlesi","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib27","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF01354535","article-title":"The probability of correctly predicting subglottic penetration from clinical observations","volume":"8","author":"Linden","year":"1993","journal-title":"Dysphagia"},{"key":"10.1016\/j.pupt.2018.06.004_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/jnnp.55.9.822","article-title":"A timed test of swallowing capacity for neurological patients","volume":"55","author":"Nathadwarawala","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.pupt.2018.06.004_bib29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S120207","article-title":"Prevalence of swallowing dysfunction screened in Swedish cohort of COPD patients","volume":"12","author":"Gonzalez Lindh","year":"2017","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00455-009-9230-3","article-title":"Outcomes of dysphagia intervention in a pulmonary rehabilitation program","volume":"25","author":"McKinstry","year":"2010","journal-title":"Dysphagia"},{"key":"10.1016\/j.pupt.2018.06.004_bib31","doi-asserted-by":"crossref","first-page":"e113048","DOI":"10.1371\/journal.pone.0113048","article-title":"Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.pupt.2018.06.004_bib32","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.amjcard.2012.10.041","article-title":"Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)","volume":"111","author":"Mentz","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.pupt.2018.06.004_bib33","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/S0954-6111(11)70010-5","article-title":"Differences between bisoprolol and carvedilol in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized trial","volume":"105","author":"Lainscak","year":"2011","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib34","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.jacc.2018.02.058","article-title":"Why is propranolol better than metoprolol in acute treatment of electrical storm?","volume":"71","author":"Cheng","year":"2018","journal-title":"JACC (J. Am. Coll. Cardiol.)"},{"key":"10.1016\/j.pupt.2018.06.004_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/jamainternmed.2017.7720","article-title":"Association of cardiovascular risk with inhaled long-acting bronchodilators in patients with chronic obstructive pulmonary disease a nested case-control study","volume":"178","author":"Wang","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib36","article-title":"Effect of low dose theophylline as adjunct in treatment of COPD","volume":"48","author":"Singh","year":"2016","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.06.004_bib37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib38","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.2147\/COPD.S118867","article-title":"Randomized controlled trials and real-world observational studies in evaluating cardiovascular safety of inhaled broncho-dilator therapy in COPD","volume":"11","author":"Kardos","year":"2016","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1164\/rccm.201711-2239OC","article-title":"Exacerbations of chronic obstructive pulmonary disease and cardiac events. A post hoc cohort analysis from the SUMMIT randomized clinical trial","volume":"198","author":"Kunisaki","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib40","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacc.2010.04.052","article-title":"Revisiting the role of oxygen therapy in cardiac patients","volume":"56","author":"Moradkhan","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pupt.2018.06.004_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1378\/chest.09-1710","article-title":"Chronic renal failure: a neglected comorbidity of COPD","volume":"137","author":"Antonelli Incalzi","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1164\/rccm.201003-0360OC","article-title":"Microalbuminuria and hypoxemia in patients with chronic obstructive pulmonary disease","volume":"182","author":"Casanova","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib43","first-page":"419","article-title":"Anemia and estimated glomerular filtration rates","volume":"44","author":"Isakov","year":"2014","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.pupt.2018.06.004_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/diacare.24.3.495","article-title":"Anaemia with erythropoietin deficiency occurs early in diabetic nephropathy","volume":"24","author":"Bosman","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pupt.2018.06.004_bib45","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1124\/dmd.109.031724","article-title":"Identification of the human enzymes responsible for the enzymatic hydrolysis of aclidinium bromide","volume":"38","author":"Albert\u00ed","year":"2010","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.pupt.2018.06.004_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/2042098612472928","article-title":"Risk of acute urinary retention associated with inhaled anticholinergics in patients with chronic obstructive lung disease: systematic review","volume":"4","author":"Loke","year":"2013","journal-title":"Ther. Adv. Drug Saf."},{"key":"10.1016\/j.pupt.2018.06.004_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/157340308784245810","article-title":"Critical review of the ankle brachial index","volume":"4","author":"Khan","year":"2008","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.pupt.2018.06.004_bib48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCULATIONAHA.109.881888","article-title":"Exercise rehabilitation in peripheral artery disease: functional impact and mechanisms of benefits","volume":"123","author":"Hamburg","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2018.06.004_bib49","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.chest.2017.08.015","article-title":"Effect of statins on COPD: a meta-analysis of randomized controlled trials","volume":"152","author":"Zhang","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11325-009-0310-2","article-title":"Nocturia and snoring: predictive symptoms for obstructive sleep apnea","volume":"14","author":"Romero","year":"2010","journal-title":"Sleep Breath."},{"key":"10.1016\/j.pupt.2018.06.004_bib51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.160.6.9902115","article-title":"Prognostic value of nutritional status in chronic obstructive pulmonary disease","volume":"160","author":"Landbo","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib52","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1164\/ajrccm\/139.6.1435","article-title":"Body weight in chronic obstructive pulmonary disease. The national institutes of health intermittent positive-pressure breathing trial","volume":"139","author":"Wilson","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib53","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/SMJ.0b013e3181d394b4","article-title":"Obesity and mortality in persons with obstructive lung disease using data from the NHANES III","volume":"103","author":"Jordan","year":"2010","journal-title":"South. Med. J."},{"key":"10.1016\/j.pupt.2018.06.004_bib54","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in Diabetes-2018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pupt.2018.06.004_bib55","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2018.06.004_bib56","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2147\/COPD.S1401","article-title":"Mechanisms of atherothrombosis in chronic obstructive pulmonary disease","volume":"3","author":"Fimognari","year":"2008","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib57","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jamda.2016.12.081","article-title":"Normal weight but low muscle mass and abdominally obese: implications for the cardiometabolic risk profile in chronic obstructive pulmonary disease","volume":"18","author":"Beijers","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.pupt.2018.06.004_bib58","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Executive summary 2018. GOLD website. http:\/\/www.goldcopd.org Published 2013 Accessed May 2018."},{"key":"10.1016\/j.pupt.2018.06.004_bib59","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2010-2729","article-title":"Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD","volume":"96","author":"Burt","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pupt.2018.06.004_bib60","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.amjmed.2010.06.019","article-title":"Inhaled corticosteroids and the risks of diabetes onset and progression","volume":"123","author":"Suissa","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0953-6205(02)00131-0","article-title":"Metformin in patients with type 2 diabetes mellitus: reconsideration of traditional contraindications","volume":"13","author":"Rachmani","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.coph.2018.01.002","article-title":"Pleiotropic effects of hypoglycemic agents: implications in asthma and COPD","volume":"40","author":"Rogliani","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.pupt.2018.06.004_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2279-042X.200985","article-title":"The effects of statins on pulmonary artery pressure in patients with chronic obstructive pulmonary disease: a randomized controlled trial","volume":"6","author":"Arian","year":"2017","journal-title":"J. Res. Pharm. Pract."},{"key":"10.1016\/j.pupt.2018.06.004_bib64","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.jacc.2006.04.039","article-title":"Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease","volume":"47","author":"Mancini","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pupt.2018.06.004_bib65","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinternmed.2010.112","article-title":"Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease","volume":"170","author":"Rutten","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib66","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy044","article-title":"Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS)","author":"Zeidler","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/j.pupt.2018.06.004_bib67","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.117.029400","article-title":"INCOSACT initiative (international collaboration of sleep apnea cardiovascular trialists). Sleep apnea and cardiovascular disease: lessons from recent trials and need for team science","volume":"136","author":"Drager","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.pupt.2018.06.004_bib68","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1378\/chest.11-1062","article-title":"Combined pulmonary fibrosis and emphysema syndrome: a review","volume":"141","author":"Jankowich","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1378\/chest.09-0538","article-title":"The syndrome of combined pulmonary fibrosis and emphysema","volume":"136","author":"Cottin","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib70","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/ijcp.12125","article-title":"Anaemia in chronic obstructive pulmonary disease. Does it really matter?","volume":"67","author":"Portillo","year":"2013","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.pupt.2018.06.004_bib71","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1183\/09031936.00137106","article-title":"Haemoglobin level and its clinical impact in a cohort of patients with COPD","volume":"29","author":"Cote","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2018.06.004_bib72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000326899","article-title":"Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses","volume":"82","author":"Boutou","year":"2011","journal-title":"Respiration"},{"key":"10.1016\/j.pupt.2018.06.004_bib73","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2466-14-24","article-title":"Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron","volume":"14","author":"Silverberg","year":"2014","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib74","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.pupt.2018.06.004_bib75","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/1753465810392264","article-title":"A new strategy with proton pump inhibitors for the prevention of acute exacerbations in COPD","volume":"5","author":"Sasaki","year":"2011","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.pupt.2018.06.004_bib76","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apt.12069","article-title":"Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia","volume":"36","author":"de Jager","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2018.06.004_bib77","doi-asserted-by":"crossref","first-page":"880","DOI":"10.14740\/jocmr2322w","article-title":"Proton pump inhibitors did not increase risk of pneumonia in patients with chronic obstructive pulmonary disease","volume":"7","author":"Lee","year":"2015","journal-title":"J. Clin. Med. Res."},{"key":"10.1016\/j.pupt.2018.06.004_bib78","first-page":"354","article-title":"Deprescribing proton pump inhibitors: evidence-based clinical practice guideline","volume":"63","author":"Farrell","year":"2017","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.pupt.2018.06.004_bib79","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1378\/chest.120.4.1184","article-title":"The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study","volume":"120","author":"Crowell","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2018.06.004_bib80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/sleep\/26.3.318","article-title":"Sleep disorders in the elderly with and without chronic airflow obstruction: the SARA study","volume":"26","author":"Bellia","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.pupt.2018.06.004_bib81","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/jgs.15157","volume":"66","author":"Vaughan","year":"2018","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.pupt.2018.06.004_bib82","series-title":"Established Populations for the Epidemiologic Study of the Elderly Resource Data Book","first-page":"86","author":"Cornoni","year":"1986"},{"key":"10.1016\/j.pupt.2018.06.004_bib83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5664\/jcsm.4540","article-title":"Sleep disorders in chronic obstructive pulmonary disease: etiology, impact, and management","volume":"11","author":"Budhiraja","year":"2015","journal-title":"J. Clin. Sleep Med."},{"key":"10.1016\/j.pupt.2018.06.004_bib84","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/gerona\/glp037","article-title":"Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults","volume":"64","author":"Kuchel","year":"2009","journal-title":"J. Gerontol. Biol. Med. Sci."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918301366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553918301366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T10:30:10Z","timestamp":1604572210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553918301366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":84,"alternative-id":["S1094553918301366"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2018.06.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pharmacological treatment of chronic comorbidities in COPD: mind the gap!","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2018.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}